Get the Stockscreener App
1.99
3.65%
0.07
After Hours:
1.97
-0.02
-1.01%
Heartbeam Inc stock is traded at $1.99, with a volume of 135.06K.
It is up +3.65% in the last 24 hours and up +3.65% over the past month.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
See More
Previous Close:
$1.92
Open:
$2.03
24h Volume:
135.06K
Relative Volume:
1.59
Market Cap:
$51.26M
Revenue:
-
Net Income/Loss:
$-14.47M
P/E Ratio:
-1.6048
EPS:
-1.24
Net Cash Flow:
$-12.19M
1W Performance:
+22.48%
1M Performance:
+3.65%
6M Performance:
-18.11%
1Y Performance:
+1.22%
1-Day Range:
$1.935
$2.1942
1-Week Range:
$1.50
$2.1942
52-Week Range:
$1.45
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.99 | 51.26M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
HeartBeam names new auditor after Marcum resignation - Investing.com
HeartBeam names new auditor after Marcum resignation By Investing.com - Investing.com UK
HeartBeam partners with AccurKardia to enhance cardiac care - Yahoo Finance
HeartBeam, AccurKardia Begin Cardiac Monitoring Partnership - Medical Product Outsourcing
HeartBeam and AccurKardia partner on ECG tech By Investing.com - Investing.com India
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - Bluefield Daily Telegraph
Heartbeam stock touches 52-week low at $1.7 amid market challenges - Investing.com Canada
Heartbeam stock touches 52-week low at $1.7 amid market challenges By Investing.com - Investing.com South Africa
Benchmark maintains $8 target on Heartbeam stock post-Q4 report By Investing.com - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-Q4 report - Investing.com
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System - Business Wire
HeartBeam reports net loss of USD 4.9M in Q4 2024 - Medical Buyer
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Earnings Call Transcript - Insider Monkey
HeartBeam’s Earnings Call Highlights Strategic Progress - TipRanks
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress - The Globe and Mail
HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves By GuruFocus - Investing.com Canada
HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations - TipRanks
Earnings call transcript: HeartBEAM Q4 2024 misses EPS forecasts - Investing.com
HeartBeam Reports Fourth Quarter and Full Year 2024 Results -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2024 Results - Business Wire
HeartBeam (NASDAQ: BEAT) To Present At Upcoming Investor And Industry Conferences - Barchart
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 - The Bakersfield Californian
Meet HeartBeam Executives: Key Investment Conferences Set for California Next Month - StockTitan
HeartBeam (NASDAQ: BEAT) to Present at Upcoming Investor and Industry Conferences - The Globe and Mail
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time - The Bakersfield Californian
HeartBeam (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M - The Globe and Mail
HeartBeam closes underwriter’s over-allotment option for PO - Medical Buyer
HeartBeam Raises $11.5M: What This Capital Injection Means for Its Commercial Launch Timeline - StockTitan
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock - Business Wire
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock - Investing.com India
Heartbeam director Richard Ferrari buys $50,000 in stock By Investing.com - Investing.com Australia
Heartbeam director Richard Ferrari buys $50,000 in stock - Investing.com India
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock By Investing.com - Investing.com Nigeria
HeartBeam announces pricing of UPO - Medical Buyer
HeartBeam submits 510(k) application to FDA for ECG software - MSN
HeartBeam sets price for $10 million stock offering - MSN
HeartBeam prices public offering of 5.88M shares; shares down - MSN
HeartBeam Secures Major Funding: FDA-Cleared Cardiac Innovation Gets $10M Boost - StockTitan
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software - The Globe and Mail
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Submits 12-Lead ECG Synthesis Software to FDA - MPO-mag
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):